Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.57 |
| ▸ | P2RX7 | Q99572 | 8/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CCKBR | P32239 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8075696 | 0.90 | SIGMAR1 (0.49) | KCNH2P2RX7SIGMAR1KMT2A | |
| SCHEMBL8075815 | 0.87 | KCNH2 (0.59) | KCNH2P2RX7SIGMAR1KMT2ACCKBR | |
| SCHEMBL8075805 | 0.86 | KCNH2 (0.56) | KCNH2XIAPCCKBRSCN9A | |
| SCHEMBL7046314 | 0.85 | KCNH2 (0.61) | KCNH2P2RX7SIGMAR1CCKBR | |
| SCHEMBL7039896 | 0.83 | KCNH2 (0.57) | KCNH2P2RX7SIGMAR1XIAPSCN9A | |
| SCHEMBL8075665 | 0.80 | KCNH2 (0.49) | KCNH2P2RX7SIGMAR1CCKBR | |
| SCHEMBL8075702 | 0.79 | ALDH1A1 (0.49) | KCNH2P2RX7SIGMAR1KMT2ACCKBR | |
| SCHEMBL7039899 | 0.77 | KCNH2 (0.56) | KCNH2P2RX7SIGMAR1SCN9A | |
| SCHEMBL7861681 | 0.77 | KCNH2 (0.60) | KCNH2P2RX7SIGMAR1SCN9A | |
| SCHEMBL7037039 | 0.77 | P2RX7 (0.48) | KCNH2P2RX7SIGMAR1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0832075-B1 | N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES | MERCK & CO INC (US) | 2000-10-11 | — | — | EP | claimed |
| US-5691331-A | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides | MERCK & CO., INC. (US) | 1997-11-25 | — | — | US | claimed |
| EP-0832075-B1 | N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES | MERCK & CO INC (US) | 2000-10-11 | — | — | EP | disclosed |
| EP-0832075-A4 | NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES | MERCK & CO INC (US) | 1998-10-07 | — | — | EP | disclosed |
| EP-0832075-A1 | NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES | Merck & Co., Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5691331-A | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides | MERCK & CO., INC. (US) | 1997-11-25 | — | — | US | disclosed |
| WO-1996040655-A1 | NOVEL N-(2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3Y L)-3-AMIDES | MERCK & CO., INC. (US) | 1996-12-19 | — | — | WO | disclosed |